One68 Global Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
One68 Global Capital's ONCE Position: Q4 2019 in Review
One68 Global Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 48,066 shares — an estimated $4.66M sold.
One68 Global Capital first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $6.15M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- One68 Global Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- One68 Global Capital sold 48,066 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $4.66M.
- One68 Global Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
- One68 Global Capital's Spark Therapeutics, Inc. Common Stock position peaked at $6.15M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on One68 Global Capital's 13F filing for Q4 2019, filed 14 Feb 2020.